m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00167)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
APOBEC4
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 14 (METTL14) [WRITER]
| Representative RNA-seq result indicating the expression of this target gene regulated by METTL14 | ||
| Cell Line | CT26 cell line | Mus musculus |
|
Treatment: METTL14 knockout CT26 cells
Control: CT26 cells
|
GSE142589 | |
| Regulation |
![]() ![]() |
logFC: 1.15E+00 p-value: 4.95E-02 |
| More Results | Click to View More RNA-seq Results | |
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | Putative C->U-editing enzyme APOBEC-4 (APOBEC4) was found to be significantly correlated with m6A regulators such as WTAP, METTL14, ZC3H13, RBM15B, and FMR1. APOBEC3A was identified as a protective factor from comprehensive analyses based on the immune microenvironment and genomic instability of ovarian cancer. APOBEC3A had the potential to serve as a promising prognostic biomarker for foretelling the survival and immunotherapy response of ovarian cancer patients. | |||
| Responsed Disease | Ovarian cancer | ICD-11: 2C73 | ||
| In-vitro Model | HEY | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0297 |
| THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
Synaptic functional regulator FMR1 (FMR1) [READER]
| Representative RNA-seq result indicating the expression of this target gene regulated by FMR1 | ||
| Cell Line | Neural precursor cells | Mus musculus |
|
Treatment: Fmr1 knockout NPCs
Control: Wild type NPCs
|
GSE121809 | |
| Regulation |
![]() ![]() |
logFC: -2.56E+00 p-value: 3.49E-02 |
| More Results | Click to View More RNA-seq Results | |
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | Putative C->U-editing enzyme APOBEC-4 (APOBEC4) was found to be significantly correlated with m6A regulators such as WTAP, METTL14, ZC3H13, RBM15B, and FMR1. APOBEC3A was identified as a protective factor from comprehensive analyses based on the immune microenvironment and genomic instability of ovarian cancer. APOBEC3A had the potential to serve as a promising prognostic biomarker for foretelling the survival and immunotherapy response of ovarian cancer patients. | |||
| Responsed Disease | Ovarian cancer | ICD-11: 2C73 | ||
| In-vitro Model | HEY | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0297 |
| THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
RNA-binding motif protein 15B (RBM15B) [WRITER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | Putative C->U-editing enzyme APOBEC-4 (APOBEC4) was found to be significantly correlated with m6A regulators such as WTAP, METTL14, ZC3H13, RBM15B, and FMR1. APOBEC3A was identified as a protective factor from comprehensive analyses based on the immune microenvironment and genomic instability of ovarian cancer. APOBEC3A had the potential to serve as a promising prognostic biomarker for foretelling the survival and immunotherapy response of ovarian cancer patients. | |||
| Responsed Disease | Ovarian cancer | ICD-11: 2C73 | ||
| In-vitro Model | HEY | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0297 |
| THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
Wilms tumor 1-associating protein (WTAP) [WRITER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | Putative C->U-editing enzyme APOBEC-4 (APOBEC4) was found to be significantly correlated with m6A regulators such as WTAP, METTL14, ZC3H13, RBM15B, and FMR1. APOBEC3A was identified as a protective factor from comprehensive analyses based on the immune microenvironment and genomic instability of ovarian cancer. APOBEC3A had the potential to serve as a promising prognostic biomarker for foretelling the survival and immunotherapy response of ovarian cancer patients. | |||
| Responsed Disease | Ovarian cancer | ICD-11: 2C73 | ||
| In-vitro Model | HEY | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0297 |
| THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
Zinc finger CCCH domain-containing protein 13 (ZC3H13) [WRITER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | Putative C->U-editing enzyme APOBEC-4 (APOBEC4) was found to be significantly correlated with m6A regulators such as WTAP, METTL14, ZC3H13, RBM15B, and FMR1. APOBEC3A was identified as a protective factor from comprehensive analyses based on the immune microenvironment and genomic instability of ovarian cancer. APOBEC3A had the potential to serve as a promising prognostic biomarker for foretelling the survival and immunotherapy response of ovarian cancer patients. | |||
| Responsed Disease | Ovarian cancer | ICD-11: 2C73 | ||
| In-vitro Model | HEY | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0297 |
| THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
Ovarian cancer [ICD-11: 2C73]
| In total 5 item(s) under this disease | ||||
| Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | Putative C->U-editing enzyme APOBEC-4 (APOBEC4) was found to be significantly correlated with m6A regulators such as WTAP, METTL14, ZC3H13, RBM15B, and FMR1. APOBEC3A was identified as a protective factor from comprehensive analyses based on the immune microenvironment and genomic instability of ovarian cancer. APOBEC3A had the potential to serve as a promising prognostic biomarker for foretelling the survival and immunotherapy response of ovarian cancer patients. | |||
| Responsed Disease | Ovarian cancer [ICD-11: 2C73] | |||
| Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
| In-vitro Model | HEY | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0297 |
| THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
| Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | Putative C->U-editing enzyme APOBEC-4 (APOBEC4) was found to be significantly correlated with m6A regulators such as WTAP, METTL14, ZC3H13, RBM15B, and FMR1. APOBEC3A was identified as a protective factor from comprehensive analyses based on the immune microenvironment and genomic instability of ovarian cancer. APOBEC3A had the potential to serve as a promising prognostic biomarker for foretelling the survival and immunotherapy response of ovarian cancer patients. | |||
| Responsed Disease | Ovarian cancer [ICD-11: 2C73] | |||
| Target Regulator | RNA-binding motif protein 15B (RBM15B) | WRITER | ||
| In-vitro Model | HEY | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0297 |
| THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
| Experiment 3 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | Putative C->U-editing enzyme APOBEC-4 (APOBEC4) was found to be significantly correlated with m6A regulators such as WTAP, METTL14, ZC3H13, RBM15B, and FMR1. APOBEC3A was identified as a protective factor from comprehensive analyses based on the immune microenvironment and genomic instability of ovarian cancer. APOBEC3A had the potential to serve as a promising prognostic biomarker for foretelling the survival and immunotherapy response of ovarian cancer patients. | |||
| Responsed Disease | Ovarian cancer [ICD-11: 2C73] | |||
| Target Regulator | Synaptic functional regulator FMR1 (FMR1) | READER | ||
| In-vitro Model | HEY | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0297 |
| THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
| Experiment 4 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | Putative C->U-editing enzyme APOBEC-4 (APOBEC4) was found to be significantly correlated with m6A regulators such as WTAP, METTL14, ZC3H13, RBM15B, and FMR1. APOBEC3A was identified as a protective factor from comprehensive analyses based on the immune microenvironment and genomic instability of ovarian cancer. APOBEC3A had the potential to serve as a promising prognostic biomarker for foretelling the survival and immunotherapy response of ovarian cancer patients. | |||
| Responsed Disease | Ovarian cancer [ICD-11: 2C73] | |||
| Target Regulator | Wilms tumor 1-associating protein (WTAP) | WRITER | ||
| In-vitro Model | HEY | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0297 |
| THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
| Experiment 5 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | Putative C->U-editing enzyme APOBEC-4 (APOBEC4) was found to be significantly correlated with m6A regulators such as WTAP, METTL14, ZC3H13, RBM15B, and FMR1. APOBEC3A was identified as a protective factor from comprehensive analyses based on the immune microenvironment and genomic instability of ovarian cancer. APOBEC3A had the potential to serve as a promising prognostic biomarker for foretelling the survival and immunotherapy response of ovarian cancer patients. | |||
| Responsed Disease | Ovarian cancer [ICD-11: 2C73] | |||
| Target Regulator | Zinc finger CCCH domain-containing protein 13 (ZC3H13) | WRITER | ||
| In-vitro Model | HEY | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0297 |
| THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
RNA Modification Sequencing Data Associated with the Target (ID: M6ATAR00167)
| In total 4 m6A sequence/site(s) in this target gene | |||
| mod ID: M6ASITE071008 | Click to Show/Hide the Full List | ||
| mod site | chr1:183653081-183653082:- | [2] | |
| Sequence | AATGTGATCCAAGCCTGGAGACAAATTGATGGTAATTATAA | ||
| Motif Score | 2.897386905 | ||
| Cell/Tissue List | endometrial | ||
| Seq Type List | m6A-seq | ||
| Transcript ID List | ENST00000308641.6; ENST00000481562.1 | ||
| External Link | RMBase: m6A_site_68544 | ||
| mod ID: M6ASITE071009 | Click to Show/Hide the Full List | ||
| mod site | chr1:183653122-183653123:- | [2] | |
| Sequence | GGAGAAAAAAAAGGAAATGGACCATCTCTTCTAACACCTGG | ||
| Motif Score | 3.622404762 | ||
| Cell/Tissue List | endometrial | ||
| Seq Type List | m6A-seq | ||
| Transcript ID List | ENST00000308641.6; ENST00000481562.1 | ||
| External Link | RMBase: m6A_site_68545 | ||
| mod ID: M6ASITE071010 | Click to Show/Hide the Full List | ||
| mod site | chr1:183653149-183653150:- | [2] | |
| Sequence | TACTTGAAACAGGGCATGGGACTTAAAGGAGAAAAAAAAGG | ||
| Motif Score | 4.065041667 | ||
| Cell/Tissue List | endometrial | ||
| Seq Type List | m6A-seq | ||
| Transcript ID List | ENST00000308641.6; ENST00000481562.1 | ||
| External Link | RMBase: m6A_site_68546 | ||
| mod ID: M6ASITE071011 | Click to Show/Hide the Full List | ||
| mod site | chr1:183653161-183653162:- | [2] | |
| Sequence | GCCTTCTGAAGCTACTTGAAACAGGGCATGGGACTTAAAGG | ||
| Motif Score | 2.20572619 | ||
| Cell/Tissue List | endometrial | ||
| Seq Type List | m6A-seq | ||
| Transcript ID List | ENST00000308641.6; ENST00000481562.1 | ||
| External Link | RMBase: m6A_site_68547 | ||
References



